Veterinary Medicines

RINOVAX, vaccino liofilizzato per polli e tacchini

Authorised
  • Turkey rhinotracheitis virus, strain VCO3, Live
Download as PDF

Product identification

Medicine name:
RINOVAX, vaccino liofilizzato per polli e tacchini
Active substance:
  • Turkey rhinotracheitis virus, strain VCO3, Live
Target species:
  • Turkey
  • Chicken (pullet for egg production, future layer)
Route of administration:
  • Inhalation use
  • Ocular use
  • Oral use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain VCO3, Live
    2.30
    log 10 50% embryo infective dose
    /
    1.00
    unit(s)
Pharmaceutical form:
This information is not available for this product.
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 6/02/2023
Download